Gianvi (Drospirenone/Ethinyl Estradiol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 5, 2021 Category: Drugs & Pharmacology Source Type: news

Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 7, 2021 Category: Drugs & Pharmacology Source Type: news

Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 3, 2021 Category: Drugs & Pharmacology Source Type: news

Syeda (Drospirenone and Ethinyl Estradiol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 19, 2021 Category: Drugs & Pharmacology Source Type: news

Nikki (Drospirenone and Ethinyl Estradiol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 30, 2021 Category: Drugs & Pharmacology Source Type: news

Ocella (Drospirenone/ethinyl Estradiol Tablets, for Oral Use) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 25, 2020 Category: Drugs & Pharmacology Source Type: news

Syeda (Drospirenone and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 18, 2019 Category: Drugs & Pharmacology Source Type: news

Jubilant Cadista Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, Due to Out-of-Specification Dissolution Test Results
Jubilant Cadista Pharmaceuticals Inc. is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to the consumer level. The affected product is being recalled due to out-of-specification (OOS) dissolution results at the 3-month stabili (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 24, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, 28x3 Blister Pack/Carton Due to Possibility of Missing/Incorrect Tablet Arrangement
Weston, Florida, Apotex Corp. is voluntarily recalling four lots of Drospirenone and Ethinyl Estradiol Tablets, USP to the patient /user level. The four recalled lots of Drospirenone and Ethinyl Estradiol Tablets, USP may possibly contain defective blisters with incorrect tablet arrangements and/or (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 21, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Nikki (Drospirenone and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 25, 2019 Category: Drugs & Pharmacology Source Type: news

Gianvi (Drospirenone/Ethinyl Estradiol) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 22, 2019 Category: Drugs & Pharmacology Source Type: news

Loryna (Drospirenone and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 21, 2019 Category: Drugs & Pharmacology Source Type: news

Birth Control Pill Recall: Defective Packaging Could Lead To Pregnancy
WESTON, Fla. (CBS) – Apotex Corp. is recalling birth control pills because of a possible packaging error that could result in an unintended pregnancy. A recall notice on the FDA’s website says there are four recalled lots of Drospirenone and Ethinyl Estradiol tablets. The defective packaging may lead someone to miss a pill or take a placebo instead of the active tablet, raising the possibility for a “loss of efficacy.” The recalled birth control pills (Image credit: FDA) So far, there have not been any reports of unintended pregnancies. The recall affects lot numbers 7DY008A, 7DY009A, 7DY010A and 7DY011A, all with ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 5, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News FDA Recall birth control Source Type: news

Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, 28x3 Blister Pack/Carton Due to Possibility of Missing/Incorrect Tablet Arrangement
Weston, Florida, Apotex Corp. is voluntarily recalling four lots of Drospirenone and Ethinyl Estradiol Tablets, USP to the patient /user level. The four recalled lots of Drospirenone and Ethinyl Estradiol Tablets, USP may possibly contain defective blisters with incorrect tablet arrangements and/or an empty blister pocket. The affected product is manufactured by Oman Pharmaceutical Products Co. LLC. Oman under the subcontract from Helm AG, Nordkanalstrasse 28, Hamburg, 20097, Germany. (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 4, 2019 Category: Food Science Source Type: news

Lo-Zumandimine (Drospirenone and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 19, 2018 Category: Drugs & Pharmacology Source Type: news